Oxybutynin Chloride
Product Images NDC 68151-3646

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 68151-3646). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl681513646)

This is a description of Oxybutynin Chloride Extended-Release tablets manufactured by IMPAX. Each tablet contains 5mg of the medication and is intended for prescription use only. The lot number is 10007041 and the expiration date is 09/14. The code "W0311143m6" is also present but its meaning is unknown.*

FDA Label Image

Chemical Structure (Oxybutynin Chloride Extended Release Tablets 1)

FDA Label Image

Figure 1 (Oxybutynin Chloride Extended Release Tablets 2)

FDA Label Image

Figure 2 (Oxybutynin Chloride Extended Release Tablets 3)

FDA Label Image

Figure (Oxybutynin Chloride Extended Release Tablets 4)

The text is a graph showing the mean change in episodes per week from baseline for Oxybutynin Chloride Extended-Release Tablets compared to a placebo. There is no further information available from the given text.*

FDA Label Image

Figure (Oxybutynin Chloride Extended Release Tablets 5)

FDA Label Image

Figure (Oxybutynin Chloride Extended Release Tablets 6)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.